MitraClip versus Pascal in transcatheter mitral valve repair (TMVR) and the most valuable outcomes following surgery: A systematic review meta-analysis of 1398 patients | ||||
| Cardiovascular Research Prove Journal | ||||
| Volume 7, Issue 1, June 2023 PDF (671.28 K) | ||||
| Document Type: Abstracts | ||||
| DOI: 10.21608/cvrepj.2023.351111 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Mitral regurgitation (MR) is a cardiac medical condition characterized by leakage of blood from the left ventricle to the left atrium during systole due to the incomplete closure of the mitral valve. MitraClip and PASCAL are innovative transcatheter edge-to-edge repair (TEER) devices used to treat MR. Whether MitraClip or PASCAL is better for achieving the best MR repair is still controversial. In the present meta-analysis, we aim to comprehensively compare both TEER device syste ms in severe MR patients and reveal which system is better depending on both efficacy and safety outcomes. | ||||
|
Statistics Article View: 73 PDF Download: 50 |
||||
